
Marketing Director
Published In: Substance Abuse | April 17 2025
Related Resources
The opioid crisis has claimed more than 720,000 lives in the United States between 2000 and 2022, and with numbers creeping much closer to a million to date. At the heart of this epidemic are potent synthetic opioids like fentanyl, but the reality of poly-drug use, often unintentional, is creeping up as an even more sinister problem.
It’s a reality that often goes unnoticed by the general public and even underreported in major headlines. While the term might sound clinical, the consequences are anything but. People are dying not just from opioids, but from dangerous drug combinations that overwhelm the body’s ability to cope. In fact, more than half of all opioid-related overdose deaths now involve more than one substance.
Some of these combinations are intentional, sought after for their intensified effects. Others are entirely accidental, where users unknowingly ingest pills or powders laced with other substances, including potent sedatives or stimulants. Either way, the result is the same: an increased risk of overdose, reduced response to lifesaving medications like naloxone, and an increasingly complex public health emergency.
Poly-drug use (also known as polysubstance abuse) refers to the practice of mixing alcohol with substances or taking more than one drug at the same time or within a short period. This can involve a wide range of substances, including prescription drugs, illegal drugs, or synthetic compounds. While the combinations vary, the underlying risks remain the same: when multiple drugs interact in the body, they can amplify one another’s effects in unpredictable and often dangerous ways.
In the context of the opioid crisis, intentional polysubstance use has become increasingly common among those with substance use disorder. People may combine prescription opioid drugs with depressant drugs like benzodiazepines to deepen sedation, or with stimulant drugs like cocaine or methamphetamine to create a euphoric high that balances out the opioid’s depressant effect. Others may take medications to manage the withdrawal symptoms from opioids, intentionally or out of desperation, without realizing the risks these mixtures carry.
But not all polysubstance use is deliberate. Many users unknowingly consume drug combinations due to contamination in the illicit supply, counterfeit pills, or mislabeled substances. This kind of unintentional exposure adds another layer of danger, especially when highly potent opioids like fentanyl are involved.
Understanding what this problem is, and how it plays out in real-world scenarios, is key to grasping why overdose deaths have become so complex and difficult to treat. It’s not just one substance driving this crisis anymore. It’s the interaction between many.
For years, public awareness campaigns and media reports have largely focused on opioids as the primary culprits behind the overdose crisis, and for good reason. Drugs like illicitly manufactured fentanyl and heroin are incredibly potent and dangerous on their own. But what’s often overlooked is how the majority of opioid-related overdose deaths involve other drug interactions.
According to data from the Centers for Disease Control (CDC), and various toxicology reports, approximately 80% of all opioid overdose deaths involve multiple substances, making poly-substance use not just a side issue, but a central, lethal driver of the crisis. Poly-drug use presents a growing pattern of substance interactions that magnify harm and complicate both prevention and treatment.
These dangerous synergies are happening every day, and they’re not limited to any one population. Polysubstance use spans demographics, intentions, and circumstances. From young recreational users drinking alcohol and experimenting with drugs at parties, to individuals managing chronic pain or mental illness with multiple prescriptions, to people with opioid use disorders just trying to avoid withdrawal.
People struggling with alcohol abuse may mix in medication to help with the effects of alcohol withdrawal, only to suffer an overdose from some other unknown substance. When emergency health professionals arrive, this could present alcohol poisoning symptoms, when instead the person is suffering from an opioid overdose.
And yet, it remains largely under the radar, less visible in news coverage, less understood by the public, and often under-addressed in policy. Until this changes, we risk missing the full picture of what’s fueling overdose deaths across the country.
The most dangerous aspect of polysubstance overdose isn’t just the number of substances involved. It’s also how they interact inside the body, often in ways that rapidly escalate risk. When opioids are taken in combination with other central nervous system depressants like benzodiazepines or alcohol, the effects don’t just add up; they multiply. Especially when it comes to slowing breathing and heart rate. This greatly increases the likelihood of respiratory arrest, the primary cause of fatal drug overdose.
Similarly, combining opioids with stimulants such as cocaine or methamphetamine creates a chaotic push-pull in the body. While stimulants can mask the sedative effects of opioids temporarily, the eventual crash can overwhelm the system. And users may not feel the warning signs of overdose until it’s too late. Below are some of the most lethal combinations currently driving opioid-related fatalities across the U.S.
This combination is one of the most common and most deadly. Both opioids and benzodiazepines are central nervous system depressants, meaning they slow down critical functions like breathing, heart rate, and brain activity. When taken together, they significantly increase the risk of respiratory depression, coma, and death.
Despite this danger, these two drug types are frequently co-prescribed, especially among patients dealing with pain and anxiety. In other cases, people turn to benzodiazepines like Xanax or Ativan to take the edge off opioid withdrawal symptoms or to enhance a high. According to the National Institute on Drug Abuse, more than 30% of opioid overdoses also involve benzodiazepines, highlighting just how pervasive and risky this combination has become.
On the opposite end of the spectrum is the combination of mixing stimulants, most notably cocaine or methamphetamine, with opioids. Known colloquially as “speedballing,” this mix creates a volatile tug-of-war in the body: the stimulant increases heart rate and energy, while the opioid slows down respiration and produces a sense of calm or euphoria.
While some users believe the stimulant will “balance out” the opioid, the reality is far more dangerous. The opposing effects can mask warning signs of overdose, leading individuals to take higher doses without realizing the strain on their cardiovascular and respiratory systems. When the stimulant wears off, the full effects of the opioid can hit all at once, often fatally. The CDC has reported sharp increases in deaths involving both synthetic opioids and stimulants over the past few years, a trend that’s only accelerated with the rise of fentanyl in the drug supply.
The increasing presence of xylazine, nitazenes, and other potent adulterants in drugs where users don’t expect them, is becoming even more concerning. These compounds are sometimes added to enhance the “high” or prolong sedation, but they come with dangerous side effects and often do not respond to standard overdose reversal agents. Unsuspecting drug users may think they’re taking a familiar painkiller or anti-anxiety medication, only to experience an overdose from hidden substances mixed in.
Illicit fentanyl has already reshaped the opioid crisis due to its extreme potency; just 2 milligrams can be lethal. But the danger doesn’t stop there. Increasingly, fentanyl is being combined or contaminated with other depressant drugs and powerful substances that further complicate overdose response and increase fatality risk.
Another class of synthetic opioids known as nitazenes have been linked to overdose deaths in both the U.S. and Europe, and are particularly dangerous because of how little is needed to cause fatal respiratory failure. Originally developed decades ago as potential pain relievers, nitazenes were never approved for medical use. Today, illegal manufacturers are mixing drugs with nitazenes, showing up in counterfeit pills and powders, and are often more potent than fentanyl itself. They are difficult to detect with standard drug tests and may require multiple doses of naloxone for reversal, if they respond at all.
Xylazine, a veterinary tranquilizer not approved for human use, is another emerging threat. Often called “tranq” on the street, xylazine enhances the sedative effects of opioids but also leads to serious health consequences. When people inject drugs like these, it can cause deep tissue wounds, severe respiratory depression, and prolonged overdoses that don’t respond to naloxone, since xylazine is not an opioid.
Another rising concern is medetomidine, another veterinary-grade sedative. Like xylazine, it slows the central nervous system and can intensify the depressant effects of opioids. The DEA has recently flagged medetomidine’s presence in the illicit drug supply, and its combination with fentanyl has been implicated in overdose clusters in multiple states.
A growing number of overdoses occur when people unknowingly consume a cocktail of substances, often with no clue what they’re really taking. This is one of the most chilling realities of today’s drug supply, and one of the hardest to combat.
At the center of this problem is drug contamination. Fentanyl is now commonly found not only in heroin but also in counterfeit pills that mimic prescription medications like oxycodone, Xanax, or even Adderall. These pills are often produced in illicit labs with no quality control, leading to inconsistent and sometimes lethal doses. A single tablet can contain multiple substances without any visible warning.
This makes every use a gamble. Unintentional poly-drug exposure creates significant challenges for first responders, treatment professionals, and harm reduction efforts. Overdoses become harder to diagnose and treat. Users may not even understand the risks they’re facing until it’s too late, and tragically, many never get a second chance.
The opioid crisis is no longer just about opioids. It’s about combinations of substances, circumstances, and systemic failures that leave people vulnerable to increasingly lethal risks. Poly-drug use has become one of the most urgent and complex facets of this public health emergency, yet it remains dangerously overlooked in mainstream conversations.
Whether the result of intentional mixing or unintentional contamination, these drug combinations are amplifying overdose rates, complicating treatment, and pushing the limits of harm reduction efforts. What’s clear is that we need awareness, compassion, and understanding in dealing with this crisis.
We need to recognize that the people caught in this crisis are often navigating deep pain, trauma, and a system that hasn’t always met them with compassion. That’s why comprehensive care, access to harm reduction tools, and trauma-informed treatment approaches matter now more than ever.
If you or someone you care about is struggling with substance use, Psyclarity Health is here to help. Our team offers evidence-based treatment and personalized support, both in-person and via telehealth, so you can access care wherever you are. You’re not alone, and recovery is possible. Reach out today.